Development of a Transgenic Flammulina velutipes Oral Vaccine for Hepatitis B
Scientists have developed a novel way to create an oral vaccine for hepatitis B using genetically modified enoki mushrooms. Instead of requiring needles and refrigeration, this approach could potentially make vaccines more accessible and easier to distribute worldwide. The researchers successfully modified the mushrooms to produce a hepatitis B protein and showed that pigs eating these mushrooms developed an immune response. Impacts on everyday life: – Could lead to needle-free vaccines that are easier to transport and store – May reduce vaccination costs and increase global access to vaccines – Demonstrates potential for using edible mushrooms as medicine delivery systems – Could make vaccination more acceptable for people afraid of needles – Shows promise for developing other oral vaccines using similar methods